HomeMREO • NASDAQ
Mereo BioPharma Group plc - ADR
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.70M | 76.61% |
Net income | -7.05M | 22.65% |
Net profit margin | — | — |
Earnings per share | -0.01 | — |
EBITDA | -14.55M | -111.10% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 69.80M | 21.56% |
Total assets | 76.39M | 14.87% |
Total liabilities | 15.42M | -3.39% |
Total equity | 60.97M | — |
Shares outstanding | 155.15M | — |
Price to book | 5.10 | — |
Return on assets | -44.51% | — |
Return on capital | -50.13% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -7.05M | 22.65% |
Cash from operations | -9.42M | -38.75% |
Cash from investing | 0.00 | — |
Cash from financing | -40.00K | — |
Net change in cash | -10.72M | -109.87% |
Free cash flow | -6.71M | — |
Previous close
$1.99
Day range
$1.72 - $2.00
Year range
$1.72 - $5.02
Market cap
290.97M USD
Avg Volume
1.44M
About
Founded
2015
Website
Employees
36
